InsidersTradesSigma
Follow the 멕아이씨에스 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 멕아이씨에스 has logged 12 reports. Market capitalisation: €24.3bn. The latest transaction was disclosed on 16 June 2026 (Purchase). Among the most active insiders: 오정택. All data is openly available.
10
Insider Decl.
n/a
Thresholds
n/a
7 ops.
Buy Volume
n/a
n/a
Sell Volume
8Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,203 of 29,063 companies
28.2
score / 100
Value16
Quality40
FCF yld-9.9%
Earn yld-9.8%
EV/EBITDA·
ROE·
Gross mgn55%
Net mgn-22%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 16 June 2026
Declarations12 total
Other
Other
12 of 12 declarations
关于 멕아이씨에스
멕아이씨에스 是一家在XKRX上市的医疗保健和制药领域的公司。它专注于为医疗领域开发创新解决方案。